Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin

Rauch, A; Egger, M; Reichen, J; Furrer, H; Swiss, HIV Cohort Study (2005). Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin. Journal of acquired immune deficiency syndromes JAIDS, 38(2), pp. 238-40. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/01.qai.0000148535.97081.72

Full text not available from this repository.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology
UniBE Contributor:	Furrer, Hansjakob
ISSN:	0894-9255
ISBN:	15671812
Publisher:	Lippincott Williams & Wilkins
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 15:00
Last Modified:	05 Dec 2022 14:18
Publisher DOI:	10.1097/01.qai.0000148535.97081.72
PubMed ID:	15671812
Web of Science ID:	000226736800018
URI:	https://boris.unibe.ch/id/eprint/25715 (FactScience: 60793)